Matthew White's Biography

Matthew White, ORISE Fellow, US FDA National Center for Toxicological Research

Dr. Matthew White earned his BS in Molecular & Cell Biology from Texas A&M University in College Station, TX. He completed his PhD in Experimental Therapeutics from The University of Texas MD Anderson Cancer Center under Dr. David J. McConkey, where his work focused on the heterogeneous response of solid tumor cells to targeted therapeutics. Most recently, he was selected as an Oak Ridge Institute of Science and Education (ORISE) postdoctoral fellow at the US FDA National Center for Toxicological Research (NCTR). He is also an adjunct faculty member at the University of Arkansas at Little Rock and Ouachita Baptist University. White’s research at NCTR focuses on the growing area of cardio-oncology. Specifically, his work investigates the cardiotoxic potential of kinase inhibitors using induced pluripotent stem cell-derived cardiomyocytes. His primary research interests are intracellular stress response pathways induced by therapeutics, and the impact of genetic heterogeneity on both therapeutic and adverse drug responses.